Xtx Topco LTD Milestone Pharmaceuticals Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 160,963 shares of MIST stock, worth $334,803. This represents 0.01% of its overall portfolio holdings.
Number of Shares
160,963
Previous 52,004
209.52%
Holding current value
$334,803
Previous $41,000
660.98%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
16.8MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$10.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$5.21 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.73 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.91 Million1.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$2.36 Million1.67% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $62.4M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...